InMed Conferences and Events
Upcoming Events
Date: June 1, 2023
Time: 11:30am ET
Eric A. Adams, CEO of InMed, will present a corporate overview followed by a Q&A session. Management will be available for virtual one-on-one meetings for qualified investors. The conference is complimentary to qualified investors. Please register through Investor Summit.
Registration: https://us06web.zoom.us/webinar/register/WN_hVitZ-efQSaO_k5EiB_bUg
A recording of the presentation will be available on this page after the event.
Date: May 31, 2023
Time: 12:00pm ET
Eric A. Adams, CEO of InMed, and Jerry Griffin, VP, Sales and Marketing of BayMedica, will co-host a presentation event titled, “Addressing The Increasing Demand For Rare Cannabinoids”.
Management will be available for a 5-10 minute Q&A session at the end of the presentation. Please send your questions for management to Tribe’s email: [email protected].
Registration: https://us06web.zoom.us/webinar/register/WN_6ZYkEADVSPOFd3g68IzQsw#/registration
A recording of the presentation will be available on this page after the event.
Past Events
Date: May 23, 2023
Time: 1:00pm ET
InMed’s CEO, Eric A. Adams, will join Robert Sassoon of Water Tower Research for a Fireside Chat.
Join the meeting where they’ll discuss:
- InMed’s rare cannabinoid pharmaceutical programs in Epidermolysis Bullosa, Glaucoma and Neurodegenerative diseases
- Bioidentical rare cannabinoid sales by BayMedica, InMed’s subsidiary
- Upcoming catalysts
Register here to join the meeting.
Date: March 9, 2023
Time: 11:00am ET
VirtualInvestorConferences.com – Life Sciences Investor Forum
InMed’s CEO, Mr Eric A. Adams, will perform a presentation followed by a questions and answers session. Management will be available for virtual one-on-one meetings with institutional and individual investors from March 9 – March 14.
Registration: https://bit.ly/3IoXpvP
Learn more about the event at www.virtualinvestorconferences.com
Date: March 8, 2023
Time: 12:30pm ET
Emerging Growth Conference
InMed’s CEO, Mr. Eric A. Adams, will perform a presentation followed by a questions and answers session. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel.
Watch the presentation here on demand
Date: November 17, 2022
Time: 8am PT / 11am ET
Registration Now Open For Tribe Public’s Webinar Event “Exploring the Neuroprotective Qualities of Rare Cannabinoids” Featuring InMed’s Management Team On November 17, 2022
Meet with InMed’s President and CEO Eric A. Adams and Eric Hsu, SVP of Preclinical Research and Development.
Date: November 17, 2022
Time: 8:00am PST / 11:00am EST
To register to join the complimentary, ZOOM webinar-based event, please visit Tribe Public LLC at INMNOV17.TribePublic.com. Once registered, participants may begin forwarding their questions for InMed’s management to Tribe Public at [email protected] or share their questions via the ZOOM chat feature during the event. Tribe Public’s Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.
Date: June 29, 2022
Time: 12:00pm ET
Dr. Shane Johnson, GM and SVP of BayMedica, InMed’s subsidiary, will be joining the panel presentation “The Intersection Between Medical and Health & Wellness” with Radicle Science’s Dr. Jeff Chen.
A discussion of the opportunities in pharmaceutical industry in addition to current health & wellness uses.
- Shane Johnson, SVP, BayMedica a Division of InMed Pharmaceuticals
- Jeff Chen, MD & MBA, CEO & Co-founder, Radicle Science
RSVP at : https://forcefamilyoffice.com/events/technology/2022-06-22-force-knowledge-cannabis/
Date: May 23-26, 2022
Presentation: The webcast recording will available on this page. Please check back for the link to access the webcast.
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To request 1-on-1 meetings with the Company, please contact your H.C. Wainwright institutional representative.
More information about the H.C. Wainwright Global Investment Conference can be found here.
Date: May 11, 2022
Presentation: The webcast recording will be posted on this page. Check back for the link.
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To request 1-on-1 meetings with the Company, please contact your Canaccord institutional representative. More information on the Canaccord Cannabis Conference can be found here.
Date: April 20-21, 2022
Management will be available for virtual one-on-one meetings with institutions and industry representatives. To request 1-on-1 meetings with the Company please contact investor relations at [email protected].
Date: March 13-15, 2022
InMed Pharmaceuticals will be presenting at the upcoming 34th Annual Roth Conference in Orange Country, CA March 13-15, 2022.
Watch the fireside chat with InMed CEO, Eric A. Adams and Roth Analyst Scott Henry:
https://wsw.com/webcast/roth43/inm2/1748056
InMed Presentation webcast link: https://wsw.com/webcast/roth43/inm/1677456
Date: Tuesday, February 15, 2022
Time: 11:00am PT / 2:00pm ET
Conference Call & Webcast*:
Tuesday, February 15, 2022, at 11:00 AM Pacific Time, 02:00 PM Eastern Time
US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745
US/CANADA Participant International Dial-In Number: +1 (914) 987-7959
Conference ID: 8645175
Webcast: https://edge.media-server.com/mmc/p/sa6ykfmv
(*Webcast replay available for 90 days)
The Company’s full financial statements and related MD&A for the second quarter of fiscal year 2022, ended December 31, 2021 will be available at www.inmedpharma.com, www.sedar.com and at www.sec.gov on February 15, 2022.
